Generation of phagocytic MAK and MAC-DC for therapeutic use: Characterization and in vitro functional properties
- 30 April 1999
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 27 (4) , 751-761
- https://doi.org/10.1016/s0301-472x(98)00070-8
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- A New Set of Monoclonal Antibodies Against Human FcγRII (CD32) and FcγRIII (CD16): Characterization and Use in Various AssaysHybridoma, 1997
- Maturation Stages of Mouse Dendritic Cells in Growth Factor–dependent Long-Term CulturesThe Journal of Experimental Medicine, 1997
- The endocytic activity of dendritic cells.The Journal of Experimental Medicine, 1995
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responsesNature, 1993
- Adoptive immunotherapy with bispecific antibodies: targeting through macrophagesResearch in Immunology, 1992
- Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1990
- The human mononuclear phagocyte high‐affinity Fc receptor, FcRI, defined by a monoclonal antibody, 10.1European Journal of Immunology, 1987
- Immune interferon: a pleiotropic lymphokine with multiple effectsImmunology Today, 1985
- IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICEThe Journal of Experimental Medicine, 1974